Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C M Sung

Showing results (11-20 of 35) with videos related to

Pageof 4
Sort By:
Cancer Research|January 1, 1985
Evaluation of the in vivo antitumor activity and in vitro cytotoxic properties of auranofin, a coordinated gold compound, in murine tumor modelsC K Mirabelli, R K Johnson, C M Sung, et al.
Biochemical Pharmacology|May 1, 1986
Interactions of gold coordination complexes with DNAC K Mirabelli, C M Sung, J P Zimmerman, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|December 6, 2001
Fibrosing cholestatic hepatitis possibly related to persistent parvovirus B19 infection in a renal transplant recipientY S Shan, P C Lee, J R Wang, et al.
Clinical Otolaryngology : Official Journal of ENT-UK ; Official Journal of Netherlands Society for Oto-Rhino-Laryngology & Cervico-Facial Surgery|November 19, 2016
Newborn hearing screening in prematurity: fate of screening failures and auditory maturationH C Yang, C M Sung, D J Shin, et al.
Cancer Research|October 1, 1988
A murine model to evaluate the ability of in vitro clonogenic assays to predict the response to tumors in vivoC K Mirabelli, C M Sung, F L McCabe, et al.
Advances in Prostaglandin, Thromboxane, and Leukotriene Research|January 1, 1995
Inhibition of CoA-independent transacylase reduces inflammatory lipid mediatorsJ D Winkler, A N Fonteh, C M Sung, et al.
The Journal of Pharmacology and Experimental Therapeutics|November 1, 1996
Inhibitors of coenzyme A-independent transacylase induce apoptosis in human HL-60 cellsJ D Winkler, T Eris, C M Sung, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 1, 1994
Effects of scalaradial, a type II phospholipase A2 inhibitor, on human neutrophil arachidonic acid mobilization and lipid mediator formationL A Marshall, J D Winkler, D E Griswold, et al.
The Journal of Biological Chemistry|April 5, 2000
Cloning and characterization of a novel human class I histone deacetylase that functions as a transcription repressorE Hu, Z Chen, T Fredrickson, et al.
Molecular Pharmacology|March 14, 1998
Beta-lactams SB 212047 and SB 216754 are irreversible, time-dependent inhibitors of coenzyme A-independent transacylaseJ D Winkler, C M Sung, M Chabot-Flecher, et al.
Pageof 4

Showing results (11-20 of 35) with videos related to

Sort By:
Pageof 4
Cancer Research|January 1, 1985
Evaluation of the in vivo antitumor activity and in vitro cytotoxic properties of auranofin, a coordinated gold compound, in murine tumor modelsC K Mirabelli, R K Johnson, C M Sung, et al.
Biochemical Pharmacology|May 1, 1986
Interactions of gold coordination complexes with DNAC K Mirabelli, C M Sung, J P Zimmerman, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|December 6, 2001
Fibrosing cholestatic hepatitis possibly related to persistent parvovirus B19 infection in a renal transplant recipientY S Shan, P C Lee, J R Wang, et al.
Clinical Otolaryngology : Official Journal of ENT-UK ; Official Journal of Netherlands Society for Oto-Rhino-Laryngology & Cervico-Facial Surgery|November 19, 2016
Newborn hearing screening in prematurity: fate of screening failures and auditory maturationH C Yang, C M Sung, D J Shin, et al.
Cancer Research|October 1, 1988
A murine model to evaluate the ability of in vitro clonogenic assays to predict the response to tumors in vivoC K Mirabelli, C M Sung, F L McCabe, et al.
Advances in Prostaglandin, Thromboxane, and Leukotriene Research|January 1, 1995
Inhibition of CoA-independent transacylase reduces inflammatory lipid mediatorsJ D Winkler, A N Fonteh, C M Sung, et al.
The Journal of Pharmacology and Experimental Therapeutics|November 1, 1996
Inhibitors of coenzyme A-independent transacylase induce apoptosis in human HL-60 cellsJ D Winkler, T Eris, C M Sung, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 1, 1994
Effects of scalaradial, a type II phospholipase A2 inhibitor, on human neutrophil arachidonic acid mobilization and lipid mediator formationL A Marshall, J D Winkler, D E Griswold, et al.
The Journal of Biological Chemistry|April 5, 2000
Cloning and characterization of a novel human class I histone deacetylase that functions as a transcription repressorE Hu, Z Chen, T Fredrickson, et al.
Molecular Pharmacology|March 14, 1998
Beta-lactams SB 212047 and SB 216754 are irreversible, time-dependent inhibitors of coenzyme A-independent transacylaseJ D Winkler, C M Sung, M Chabot-Flecher, et al.
Pageof 4